🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Intestinal Failure

Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction NCT06652087NA1 site📍 Moscow I.M. Sechenov First Moscow State Medical University · Tests: Rifaximin, Standard HFpEF treatment Measurement of Intestinal Permeability in Intensive Care Patients With Single or Multiple Organ Failure NCT06845865n/a1 site📍 Vincennes Direction Centrale du Service de Santé des Armées · Tests: enteric dyed solution Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection Weaning is Winning? (WeWin Study) NCT06525753n/a1 site📍 Toronto The Hospital for Sick Children · Tests: Weaning off Parenteral Nutrition A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis NCT06461208Phase 323 sites📍 Basildon📍 Bournemouth📍 Bristol King's College London · Tests: Encapsulated FMT, Placebo Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial NCT06699433NA3 sites📍 Guiyang📍 Fuzhou📍 Yisa Southern Medical University, China · Tests: Virtual standardized patients (VSPs), Case teaching manuals, Case teaching videos Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS NCT07197944Phase 333 sites📍 Chicago📍 St Louis📍 Omaha Zealand Pharma · Tests: Glepaglutide, Placebo Resting Energy Expenditure by Gastrointestinal Functional Status NCT07714499NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Protocol-Defined Metabolic and Body Composition Assessment AI-driven Total Parenteral Nutrition Platform NCT07414576NA1 site📍 Stanford Takeoff41, Inc. · Tests: AI-driven total parenteral nutrition (TPN) Drug Interaction Potential of Pro-Inflammatory Conditions NCT07360938n/a1 site📍 Indianapolis Indiana University · Tests: None (Observational) Becotatug Vedotin Plus Pucotenlimab for Metastatic Colorectal Cancer NCT07884188Phase 21 site📍 Shanghai Fudan University · Tests: Becotatug Vedotin (MRG003), Pucotenlimab Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease NCT07621367NA1 site📍 Nanjing The Second Hospital of Nanjing Medical University · Tests: Oxygen (O2) -Sham group, Sham -Oxygen (O2) group Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial NCT07106034Phase 21 site📍 Shanghai Shanghai Pudong Hospital · Tests: Ongericimab + Toripalimab + Bevacizumab + FOLFOX, Ongericimab + Toripalimab + Bevacizumab + FOLFIRI Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects NCT04775706Phase 215 sites📍 Boston📍 Cleveland📍 Leuven Hanmi Pharmaceutical Company Limited · Tests: HM15912 Active, Placebo Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure NCT04629014n/a14 sites📍 Birmingham📍 Aurora📍 Hartford Boston Children's Hospital Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Microbiota-Inflammation-Brain Axis in Heart Failure: New Functional Food for the Prevention of undeRnutrition in Older NCT07076329NA1 site📍 Florence Azienda Ospedaliero-Universitaria Careggi · Tests: Ambrosia bar Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter) NCT07351357Phase 46 sites📍 Kwai Chung📍 Sham Shui Po📍 Shatin Chinese University of Hong Kong · Tests: Bisacodyl 5 mg Enhanced Nutritional Optimization in LVAD Trial NCT05655910NA1 site📍 New York Columbia University · Tests: Ensure Surgery Immunonutrition shake Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support NCT06910943Phase 2, Phase 318 sites📍 Aurora📍 Miami Lakes📍 Chicago Protara Therapeutics · Tests: Choline Chloride for Injection, Placebo KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure NCT05879835NA8 sites📍 Boston📍 Omaha📍 New York SterileCare Inc. · Tests: KiteLock 4% Sterile Catheter Lock Solution, Heparin Lock Solution Comparing Three Rescue Bowel Preparation Regimens for Colonoscopy After Failed Cleansing NCT07557173NA1 site📍 Benevento Ospedale San Pio · Tests: Drug, Drug, Drug A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD). NCT05919680Phase 213 sites📍 Scottsdale📍 San Francisco📍 Washington D.C. NorthSea Therapeutics B.V. · Tests: NST-6179 Part A, NST-6179 Part B, Matched Placebo Gut Microbiome in Orthopaedics: Revision Total Knee Arthroplasty NCT06951477n/a1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Revision Total Knee Arthroplasty Ivarmacitinib Combined With Camrelizumab and Fruquintinib for Patients With Metastatic Colorectal Cancer After Failure of Second-line or Later Treatment, A Phase II Study NCT07896096Phase 21 site📍 Wuhan Renmin Hospital of Wuhan University · Tests: Ivarmacitinib + Camrelizumab + Fruquintinib Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) NCT06904872Phase 28 sites📍 Aachen📍 Berlin📍 Essen Napo Therapeutics, S.p.A. · Tests: Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients NCT07202910n/a1 site📍 Gothenburg Sahlgrenska University Hospital Fecal Microbiota Transplantation for Liver Failure NCT05170971NA1 site📍 Ningbo Ningbo Medical Center Lihuili Hospital · Tests: fecal microbiota transplantation Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer NCT06763029Phase 21 site📍 Shanghai Fudan University · Tests: Irinotecan liposomes combined with cetuximab + vermofenib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy